BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37229633)

  • 1. The Role of Positron Emission Tomography for the Management of Sinonasal Malignancies: A Systematic Review.
    El-Adem D; Yang N; Gudis DA
    Am J Rhinol Allergy; 2023 Sep; 37(5):593-610. PubMed ID: 37229633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of first positron emission tomography-computed tomography scan as a prognostic tool following treatment of sinonasal and skull base malignancies.
    Abu-Ghanem S; Yafit D; Ghanayem M; Abergel A; Yehuda M; Fliss DM
    Head Neck; 2019 Mar; 41(3):701-706. PubMed ID: 30521131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18-FDG-PET in the initial staging of sinonasal malignancy.
    Ramakrishnan VR; Lee JY; O'Malley BW; Palmer JN; Chiu AG
    Laryngoscope; 2013 Dec; 123(12):2962-6. PubMed ID: 23877974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of positron emission tomography in management of sinonasal neoplasms--a single institution's experience.
    Lamarre ED; Batra PS; Lorenz RR; Citardi MJ; Adelstein DJ; Srinivas SM; Scharpf J
    Am J Otolaryngol; 2012; 33(3):289-95. PubMed ID: 21925763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal patterns of
    Schwartz JS; Brooks SG; Stubbs V; Ghosh A; Tajudeen BA; Khalili S; Palmer JN; Lee JY; Nabavizadeh SA; Learned KO; Adappa ND
    Int Forum Allergy Rhinol; 2016 Dec; 6(12):1301-1307. PubMed ID: 27383662
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
    Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Diagnosis of Sinonasal Lymphoma and Squamous Cell Carcinoma on CT, MRI, and PET/CT.
    Kim SH; Mun SJ; Kim HJ; Kim SL; Kim SD; Cho KS
    Otolaryngol Head Neck Surg; 2018 Sep; 159(3):494-500. PubMed ID: 29661053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of 68Ga-PSMA PET/CT scan in biochemical recurrence after primary treatment for prostate cancer: a systematic review of the literature.
    Eissa A; Elsherbiny A; Coelho RF; Rassweiler J; Davis JW; Porpiglia F; Patel VR; Prandini N; Micali S; Sighinolfi MC; Puliatti S; Rocco B; Bianchi G
    Minerva Urol Nefrol; 2018 Oct; 70(5):462-478. PubMed ID: 29664244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors.
    Kuan EC; Wang EW; Adappa ND; Beswick DM; London NR; Su SY; Wang MB; Abuzeid WM; Alexiev B; Alt JA; Antognoni P; Alonso-Basanta M; Batra PS; Bhayani M; Bell D; Bernal-Sprekelsen M; Betz CS; Blay JY; Bleier BS; Bonilla-Velez J; Callejas C; Carrau RL; Casiano RR; Castelnuovo P; Chandra RK; Chatzinakis V; Chen SB; Chiu AG; Choby G; Chowdhury NI; Citardi MJ; Cohen MA; Dagan R; Dalfino G; Dallan I; Dassi CS; de Almeida J; Dei Tos AP; DelGaudio JM; Ebert CS; El-Sayed IH; Eloy JA; Evans JJ; Fang CH; Farrell NF; Ferrari M; Fischbein N; Folbe A; Fokkens WJ; Fox MG; Lund VJ; Gallia GL; Gardner PA; Geltzeiler M; Georgalas C; Getz AE; Govindaraj S; Gray ST; Grayson JW; Gross BA; Grube JG; Guo R; Ha PK; Halderman AA; Hanna EY; Harvey RJ; Hernandez SC; Holtzman AL; Hopkins C; Huang Z; Huang Z; Humphreys IM; Hwang PH; Iloreta AM; Ishii M; Ivan ME; Jafari A; Kennedy DW; Khan M; Kimple AJ; Kingdom TT; Knisely A; Kuo YJ; Lal D; Lamarre ED; Lan MY; Le H; Lechner M; Lee NY; Lee JK; Lee VH; Levine CG; Lin JC; Lin DT; Lobo BC; Locke T; Luong AU; Magliocca KR; Markovic SN; Matnjani G; McKean EL; Meço C; Mendenhall WM; Michel L; Na'ara S; Nicolai P; Nuss DW; Nyquist GG; Oakley GM; Omura K; Orlandi RR; Otori N; Papagiannopoulos P; Patel ZM; Pfister DG; Phan J; Psaltis AJ; Rabinowitz MR; Ramanathan M; Rimmer R; Rosen MR; Sanusi O; Sargi ZB; Schafhausen P; Schlosser RJ; Sedaghat AR; Senior BA; Shrivastava R; Sindwani R; Smith TL; Smith KA; Snyderman CH; Solares CA; Sreenath SB; Stamm A; Stölzel K; Sumer B; Surda P; Tajudeen BA; Thompson LDR; Thorp BD; Tong CCL; Tsang RK; Turner JH; Turri-Zanoni M; Udager AM; van Zele T; VanKoevering K; Welch KC; Wise SK; Witterick IJ; Won TB; Wong SN; Woodworth BA; Wormald PJ; Yao WC; Yeh CF; Zhou B; Palmer JN
    Int Forum Allergy Rhinol; 2024 Feb; 14(2):149-608. PubMed ID: 37658764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis.
    Perera M; Papa N; Roberts M; Williams M; Udovicich C; Vela I; Christidis D; Bolton D; Hofman MS; Lawrentschuk N; Murphy DG
    Eur Urol; 2020 Apr; 77(4):403-417. PubMed ID: 30773328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of whole-body
    Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z
    Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):847-855. PubMed ID: 30604061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of FDG avid Benign Sinonasal Schneiderian Papilloma: A Case Report and Review of the Literature.
    Shafqat I; Ho AS; Manzoor D; Balzer B; Wu AW
    Ann Otol Rhinol Laryngol; 2021 Apr; 130(4):424-428. PubMed ID: 32847383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers.
    Facey K; Bradbury I; Laking G; Payne E
    Health Technol Assess; 2007 Oct; 11(44):iii-iv, xi-267. PubMed ID: 17999839
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Workman AD; Glicksman JT; Parasher AK; Carey RM; Brooks SG; Kennedy DW; Nabavizadeh SA; Learned KO; Palmer JN; Adappa ND
    Otolaryngol Head Neck Surg; 2017 Dec; 157(6):1068-1074. PubMed ID: 28809123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between
    Felix-Ravelo M; Bey A; Arous F; Paris-Grandpierre S; Jankowski R; Nguyen DT
    Acta Otolaryngol; 2017 Feb; 137(2):191-195. PubMed ID: 27576899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Primary Staging of Newly Diagnosed Prostate Cancer: A Systematic Review of the Literature.
    Abrams-Pompe RS; Fanti S; Schoots IG; Moore CM; Turkbey B; Vickers AJ; Walz J; Steuber T; Eastham JA
    Eur Urol Oncol; 2021 Jun; 4(3):370-395. PubMed ID: 33272865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
    Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
    Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of survival with combining quantitative
    Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z
    Head Neck; 2019 Sep; 41(9):3080-3089. PubMed ID: 31041831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.